Modulation of the specificity and activity of a cellular promoter in an adenoviral vector

Human Gene Therapy

Volumn 8, Issue 4, 1997, Pages 403-410

  Shi, Qinwei ^a   Wang, Yanchun ^b   Worton, Ronald ^b  

^a Spectral Diagnostics Inc   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

MYOSIN LIGHT CHAIN; VIRUS VECTOR;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; GENE EXPRESSION; MOUSE; MUSCLE CELL; NONHUMAN; REPORTER GENE; TISSUE SPECIFICITY; VIRUS GENOME; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALIA;

EID: 0030895597     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1997.8.4-403     Document Type: Article

References (32)

1. ACSADI, G., DICKSON, G., LOVE, D.R., JANI, A., WALSH, F.S., GURUSINGHE, A., WOLFF, J.A., and DAVIES, K.E. (1991). Human dystrophin expression in mdx mice after intramuscular injection of DNA constructs. Nature 352, 815-818.
2. ACSADI, G., JANI, A., MASSIE, B., SIMONEAU, M., HOLLAND, P., BLASCHUK, K., and KARPATI, G. (1994). A differential efficiency of adenovirus-mediated in vivo gene transfer into skeletal muscle cells of different maturity. Hum. Mol. Gen. 3, 579-584.
3. AUSUBEL, F.M., BRENT, R., KINGSTON, R.E., MOORE, D.D., SEIDMAN, J.G., SMITH, J.A., and STRUHL, K. (1987). Current Protocols in Molecular Biology. (John Wiley & Sons, New York) pp. 9.6.3-9.6.4.
4. BABISS, L.E., FRIEDMAN, J.M., and DARNEL, JR. J.E. (1986). Cellular promoter incorporated into the adenovirus genome: Effects of viral regulatory elements on transcription rates and cell specificity of albumin and β-globin promoters. Mol. Cell. Biol. 6, 3798-3806.
5. BABISS, L.E. (1989). The cellular transcription factor E2F requires viral E1A and E4 gene products for increased DNA-binding activity and functions to stimulate adenovirus E1A gene expression. J. Virol. 63, 2709-2717.
6. BETT, A.J., HADDARA, W., PREVEC, L., and GRAHAM, F.L. (1994). An efficient and flexible system for construction of adenovirus vectors with insertions and deletions in early regions 1 and 3. Proc. Natl. Acad. Sci. USA 91, 8802-8806.
7. BONNEROT, C., ROCANCOURT, D., BRIAND, P., GRIMBER, G., and NICOLAS, J.F. (1987). A β-galactosidase hybrid protein targeted to nuclei as a marker for developmental studies. Proc. Natl. Acad. Sci. USA 84, 6795-6799.
8. CLEMENS, P.R., KRAUSE, T.L., CHAN, S., KORB, K.E., GRAHAM, F.L., and CASKEY, C.T. (1995). Recombinant truncated dystrophin minigenes: construction, expression, and adenoviral delivery. Hum. Gene Ther. 6, 1477-1485.
9. DAVIDSON, B.L., ALLEN, E.D., KOZARSKY, K.F., WILSON, J.M., and ROESSLER, B.J. (1993). A model system for in vivo gene transfer into the central nervous system using an adenoviral vector. Nature Genet. 3, 219-223.
10. DAVIS, H.L., DEMENEIX, B.A., QUANTIN, B., COULOMBE, J., and WHALEN, R.G. (1993). Plasmid DNA is superior to viral vectors for direct gene transfer into adult mouse skeletal muscle. Hum. Gene Ther. 4, 733-740.
11. DUNCKLEY, M.G., WELLS, D.J., WALSH, F.S., and DICKSON, G. (1993). Direct retroviral-mediated transfer of a dystrophin minigene into mdx mouse muscle in vivo. Hum. Mol. Genet. 2, 717-723.
12. ENGELHARDT, J.F., YANG, Y.P., STRATFORD-PERRICAUDET, L.D., ALLEN, E.D., KOZARSKY, K., PERRICAUDET, M., YANKASKAS, J.R., and WILSON, J.M. (1993). Direct gene transfer of human CFTR into human bronchial epithelia of xenografts with E1-deleted adenovirus. Nature Genet. 4, 27-34.
13. FISHER, K.J., CHOI, H., BURDA, J., CHEN, S.J., and WILSON, J.M. (1996). Recombinant adenovirus deleted of all viral genes for gene therapy of cystic fibrosis. Virology 217, 11-22.
14. FODOR, W.L., DARRAS, B., SEHARASEYON, J., FALKENTHAL, S., FRANCKE, U., and VANIN, E.F. (1989). Human ventricular/slow twitch myosin alkali light chain gene characterization, sequence, and chromosomal location. J. Biol. Chem. 264, 2143-2149.
15. FRIEDMAN, J.M., BABISS, L.E., CLAYTON, D.F., and DARNELL, JR. J.E. (1986). Cellular promoter incorporated into the adenovirus genome: cell specificity of albumin and immunoglobulin expression. Mol. Cell. Biol. 6, 3791-3797.
16. GILGENKRANTZ, H., DUBOC, D., JUILLARD, V., COUTON, D., PAVIRANI, A., GUILLET, J.K., BRIAND, P., and KAHN, A. (1995). Transient expression of genes transferred in vivo into heart using first-generation adenoviral vectors: Role of the immune response. Hum. Gene Ther. 6, 1265-1274.
17. GORMAN, C.M., MOFFAT, L., and HOWARD, B. (1983). Recombinant genomes which express chloramphenicol acetyl transferase in mammalian cells. Mol. Cell. Biol. 2, 1044-1051.
18. GRAHAM, F.L. (1987). Growth of 293 cells in suspension culture. J. Gen. Virol. 68, 937-940.
19. GRAHAM, F.L., and VAN DER EB, A.J. (1973). A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52, 456-467.
20. GRAHAM, F.L., and PREVEC, L. (1991). Manipulation of adenovirus vectors. In Methods in Molecular Biology: Gene Transfer and Expression Protocols, vol. 7. E.J. Murray, ed. (Humana Press Inc., Clifton, NJ) pp. 109-128.
21. GRAHAM, F.L., SMILEY, J., RUSSELL, W.C., and NAIRN, R. (1977). Characteristics of a human cell line transformed by DNA from human adenovirus 5. J. Gen. Virol. 36, 59-72.
22. HEARING, P., and SHENK, T. (1983). The adenovirus type 5 E1A transcriptional control region contains a duplicated enhancer element. Cell 33, 695-703.
23. HERBOMEL, P., BOURACHOT, B., and YANIV, M. (1984). Two distinct enhancers with different cell specificities coexist in the regulatory region of polyoma. Cell 39, 653-662.
24. KARLSSON, S., DORREN, K.V., SCHWEIGER, S.G., NIENHUIS, A.W., and GLUZMAN, Y. (1986). Stable gene transfer and tissue-specific expression of a human globin gene using adenoviral vectors. EMBO J. 5, 2377-2385.
25. LEE, S.W., TRAPNELL, B.C., RADE, J.J., VIRMANI, R., and DICHEK, D.A. (1993). In vivo adenoviral vector-mediated gene transfer into balloon-injured rat carotid arteries. Circ. Res. 73, 797-807.
26. LI, Q.T., KAY, M.A., FINEGOLD, M., STRATFORD-PERRICAUDET, L., and WOO S.L.C. (1993). Assessment of recombinant adenoviral vectors for hepatic gene therapy. Hum. Gene Ther. 4, 403-409.
27. RAGOT, T., VINCENT, N., CHAFEY, P., VIGNE, E., GILGENKRANTZ, H., COUTON, D., CARTAUD, J., BRIAND, P., KAPLAN, J.-C., PERRICAUDET, M., and KAHN, A. (1993). Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice. Nature 361, 647-650.
28. SAMBROOK, J., FRITSCH, E.F., and MANIATIS, T. (1989). Molecular Cloning: A Laboratory Manual. (Cold Spring Harbor Laboratory Press, New York, NY).
29. SANES, J.R., RUBENSTEIN, J.L.R., and NICOLAS J.F. (1986). Use of a recombinant retrovirus to study post-implantation cell lineage in mouse embryos. EMBO J. 5, 3133-3142.
30. SHI, Q., LI, R., MICKLE, D.A.G. and JACKOWSKI, G. ( 1992). Analysis of the upstream regulatory region of human ventricular myosin light chain 1 gene. J. Mol. Cell Cardiol. 24, 1221-1229.
31. STRATFORD-PERRICAUDET, L.D., MAKEH, I., PERRICAUDET, M., and BRIAND, P. (1992). Widespread long-term gene transfer to mouse skeletal muscles and heart. J. Clin. Invest. 90, 626-630.
32. TRASK, R.V., KOSTER, J.C., RITCHIE, M.E., and BILLADELLO, J.J. (1992). The human M creatine kinase gene enhancer contains multiple functional interacting domains. Nucleic Acids Res. 20, 2313-2320.